Epidemiology Practice Questions

Q: The Kaplan-Meier method is used for estimating what?

Survival. ### Explanation **Correct Answer: A. Survival** The **Kaplan-Meier method** (also known as the product-limit method) is a non-parametric statistic used to estimate the **survival function** from time-to-event data. In medical research, it is the gold standard for analyzing "time to death" or "time to failure" of a treatment. The key strength of this method is its ability to handle **censored data**—cases where the event of interest (e.g., death) does not occur during the study period or the patient drops out. It calculates the probability of an event occurring at specific time intervals, resulting in the characteristic "step-ladder" **Kaplan-Meier Survival Curve**. **Why other options are incorrect:** * **B. Prevalence:** This refers to the total number of existing cases in a population at a given time. It is a "snapshot" and does not involve time-to-event analysis. * **C. Incidence:** This measures the number of *new* cases occurring in a population over a period. While it involves time, it does not account for the probability of survival or censored data like Kaplan-Meier. * **D. Frequency:** This is a general term for counts or proportions (like rates and ratios) and is not a specific statistical method for survival analysis. **High-Yield Clinical Pearls for NEET-PG:** * **Log-Rank Test:** This is the statistical test used to compare two different Kaplan-Meier survival curves (e.g., Drug A vs. Placebo). * **Hazard Ratio (HR):** Often reported alongside Kaplan-Meier; it represents the theoretical risk of an event occurring at any specific point in time. * **Median Survival Time:** This is the time point at which 50% of the study subjects are still alive; it is easily identified on a Kaplan-Meier plot where the curve crosses the 0.5 probability mark.

Q: An investigator is studying the impact seatbelts have on the severity of injuries incurred during a motor vehicle accident. Which of the following study designs would be most appropriate for answering this question?

Case-control study. **Explanation:** The primary objective of this study is to investigate the association between an exposure (seatbelt use) and an outcome (severity of injury). **Why Case-Control is the Correct Answer:** In injury epidemiology, particularly for motor vehicle accidents (MVAs), the outcome (injury) has already occurred by the time the investigator begins the study. A **Case-Control study** is the most appropriate and practical design here. * **Cases:** Individuals who sustained severe injuries. * **Controls:** Individuals involved in similar accidents who sustained minor or no injuries. The investigator then looks **backwards in time** (retrospective) to determine the frequency of seatbelt use in both groups. This design is efficient for studying outcomes that are sudden or "acute" events like accidents. **Analysis of Incorrect Options:** * **A. Case Series:** This only describes a group of injured patients without a comparison group. It cannot establish an association or calculate risk. * **C. Cohort Study:** While theoretically possible, it is impractical and unethical to follow a group of people and wait for them to have accidents to see if seatbelts worked. It would require a massive sample size and a very long duration. * **D. Clinical Trial:** It is unethical to randomly assign one group to "no seatbelt" (the intervention) and expose them to the risk of injury in a trial setting. **NEET-PG High-Yield Pearls:** * **Directionality:** Case-control is "Retrospective" (Effect to Cause), whereas Cohort is "Prospective" (Cause to Effect). * **Measure of Association:** Case-control studies use **Odds Ratio (OR)**; Cohort studies use **Relative Risk (RR)**. * **Best for Rare Diseases:** Case-control is the design of choice for rare diseases or outcomes with long latency periods. * **Injury Epidemiology:** For sudden-onset events like MVAs or outbreaks, case-control is often the most feasible initial study design.

Q: What is the quarantine period for yellow fever?

6 days. **Explanation:** The quarantine period for a disease is defined as the maximum incubation period of that disease. For **Yellow Fever**, the maximum incubation period is **6 days**. 1. **Why 6 days is correct:** According to International Health Regulations (IHR), the incubation period for Yellow Fever ranges from 3 to 6 days. Therefore, travelers arriving from endemic zones without a valid vaccination certificate are placed under "quarantine" (isolation) for a period of 6 days from the date of last possible exposure to ensure they do not develop or spread the virus. 2. **Why other options are incorrect:** * **1 & 2 days:** These are too short and do not cover the full potential incubation window of the virus. * **10 days:** While the Yellow Fever vaccine becomes legally valid **10 days after administration** (the time required for protective antibodies to develop), it is not the duration of the quarantine period itself. **High-Yield NEET-PG Clinical Pearls:** * **Vaccine Validity:** The Yellow Fever vaccine (17D strain) is valid for **life** (as per WHO amendments since 2016), but for international travel purposes, it starts being valid 10 days after vaccination. * **Vector:** The primary vector is the *Aedes aegypti* mosquito. * **Quarantine vs. Isolation:** Quarantine applies to healthy people who were exposed; Isolation applies to infected/ill individuals. * **Other Quarantine Periods:** * Cholera: 5 days * Plague: 6 days * Yellow Fever: 6 days

Q: Which of the following is the best indicator of the severity of a short-duration acute disease?

Case fatality rate. **Explanation** **Case Fatality Rate (CFR)** is the best indicator of the **virulence** or **severity** of a disease. It represents the proportion of people diagnosed with a specific disease who die from it within a specified period. * **Formula:** (Total deaths from a disease / Total number of diagnosed cases of that disease) × 100. * **Why it is correct:** For short-duration acute diseases (e.g., Ebola, Cholera, or Meningococcemia), CFR directly measures the killing power of the pathogen. A high CFR indicates a more "severe" or "lethal" disease. **Analysis of Incorrect Options:** * **A. Cause-specific death rate:** This measures the mortality risk in the *entire population* (e.g., deaths per 1,000 people). It is influenced by both the severity of the disease and its prevalence in the community, making it a measure of the disease's overall burden rather than individual severity. * **B. 5-year survival:** This is the gold standard for assessing the prognosis and treatment effectiveness of **chronic diseases** (e.g., Cancers). It is irrelevant for short-duration acute illnesses. * **D. Standardized Mortality Ratio (SMR):** This is used to compare the observed deaths in a specific study group with the expected deaths in the general population. It is primarily used in occupational epidemiology to account for confounding factors like age. **High-Yield NEET-PG Pearls:** * **CFR vs. Mortality Rate:** CFR is a ratio (though often expressed as a percentage), while Mortality Rate is a true rate (includes time and population at risk). * **Complement of CFR:** The survival rate is (100 - CFR). * **Virulence:** In epidemiology, CFR is the primary clinical measure of a pathogen's virulence. * **Acute vs. Chronic:** Use CFR for acute infections; use 5-year survival for chronic conditions.

Q: The Naranjo algorithm is used for:

Calculating the probability of adverse drug reactions. **Explanation:** The **Naranjo Algorithm** (or Naranjo Scale) is a standardized questionnaire used in clinical pharmacology and pharmacovigilance to determine the **causality** of an Adverse Drug Event. It consists of 10 objective questions (e.g., Did the reaction appear after the drug was administered? Did it improve when the drug was discontinued? Did it reappear upon rechallenge?). Each answer is assigned a score, and the total score categorizes the probability of the Adverse Drug Reaction (ADR) as: * **≥ 9:** Definite * **5–8:** Probable * **1–4:** Possible * **0:** Doubtful **Analysis of Incorrect Options:** * **Option A:** Environmental factors (like temperature or humidity) may affect drug stability, but the Naranjo scale specifically evaluates the clinical relationship between a drug and a patient's reaction. * **Option B:** Parametric data evaluation refers to statistical tests (like t-tests or ANOVA) used when data follows a normal distribution. Naranjo is a clinical scoring system, not a statistical distribution test. * **Option D:** While age or gender (demographics) can influence pharmacokinetics, the Naranjo algorithm focuses on the temporal and clinical link of the adverse event rather than demographic profiling. **High-Yield Clinical Pearls for NEET-PG:** * **WHO-UMC Scale:** Another common tool for ADR causality assessment (often compared with Naranjo). * **Pharmacovigilance:** The science of detecting, assessing, understanding, and preventing adverse effects. * **Yellow Card Scheme:** A famous spontaneous reporting system for ADRs (UK-based, but frequently asked). * **Pharmacovigilance Programme of India (PvPI):** Coordinated by the Indian Pharmacopoeia Commission (IPC).

Q: Immunity by vaccination is:

Active acquired. **Explanation:** Immunity is broadly classified based on how the body acquires protection against pathogens. The correct answer is **Active Acquired Immunity**. **1. Why Active Acquired?** * **Active:** This means the individual’s own immune system is stimulated to produce antibodies or specialized cells (T-cells). In vaccination, an antigen (live-attenuated, killed, or subunit) is introduced, triggering the body’s immune machinery to create a memory response. * **Acquired (Artificial):** This refers to immunity obtained through deliberate medical intervention rather than natural exposure. **2. Analysis of Incorrect Options:** * **Active Natural:** This occurs when a person is naturally infected by a disease-causing agent (e.g., developing lifelong immunity after a natural Measles infection). * **Passive Natural:** This involves the transfer of pre-formed antibodies from mother to child via the placenta (IgG) or breast milk (IgA). The recipient’s immune system remains passive. * **Passive Acquired (Artificial):** This involves the administration of ready-made antibodies (immunoglobulins or antisera) for immediate protection, such as Anti-Rabies Serum (ARS) or Tetanus Immunoglobulin (TIG). **High-Yield Clinical Pearls for NEET-PG:** * **Speed vs. Duration:** Active immunity takes time to develop (latent period) but is long-lasting. Passive immunity is immediate but temporary. * **Adoptive Immunity:** A subset of acquired immunity achieved by transferring immunocompetent cells (like lymphocytes), often used in bone marrow transplants. * **Combined Immunization:** Giving both active (vaccine) and passive (IG) components simultaneously at different sites (e.g., Post-exposure prophylaxis for Rabies or Hepatitis B).

Q: In a case-control study, the disease is found to be more common in the group consuming coffee compared to the control group. What is the significance of this finding?

Caffeine is associated with the occurrence of the disease.. ### Explanation **1. Why Option C is Correct:** In epidemiology, a **Case-Control Study** is an observational, analytical study designed to identify associations between an exposure (coffee/caffeine) and an outcome (disease). When a factor is found more frequently in the "cases" than in the "controls," it indicates a **statistical association**. This means the exposure and the disease occur together more often than would be expected by chance. However, an association does not automatically imply that the exposure *caused* the disease. **2. Why Other Options are Incorrect:** * **Option A:** A case-control study alone cannot establish a **cause-and-effect relationship**. Causality requires meeting the "Bradford Hill Criteria" (e.g., temporality, strength, dose-response) and is better supported by Cohort studies or Randomized Controlled Trials (RCTs). * **Option B:** Case-control studies do not measure the "median" of a disease. They primarily measure the **Odds Ratio (OR)**. Since the study starts with diseased individuals, it cannot calculate Incidence or the median duration/onset of the disease in the general population. * **Option C:** This is a false premise. Controls are chosen because they do not have the disease *at the start of the study*, but they remain at risk and could potentially develop the disease in the future. **3. High-Yield Clinical Pearls for NEET-PG:** * **Direction of Study:** Retrospective (Proceeds from Effect to Cause). * **Measure of Association:** Odds Ratio (OR). * **Key Advantage:** Best for studying **rare diseases** or diseases with long latency periods. * **Key Disadvantage:** Highly prone to **Recall Bias** and Selection Bias. * **Matching:** Done in case-control studies to eliminate the effects of confounding variables.

Question 1

The Kaplan-Meier method is used for estimating what?

Accepted Answer

Survival

Answer

Prevalence

Answer

Incidence

Answer

Frequency

Question 2

An investigator is studying the impact seatbelts have on the severity of injuries incurred during a motor vehicle accident. Which of the following study designs would be most appropriate for answering this question?

Accepted Answer

Case-control study

Answer

Case series

Answer

Cohort study

Answer

Clinical trial

Question 3

What is the quarantine period for yellow fever?

Accepted Answer

6 days

Answer

1 day

Answer

2 days

Answer

10 days

Question 4

Which of the following is the best indicator of the severity of a short-duration acute disease?

Accepted Answer

Case fatality rate

Answer

Cause-specific death rate

Answer

5-year survival

Answer

Standardized mortality ratio

Question 5

Reverse cold chain is used for which of the following purposes?

Accepted Answer

Carrying stool samples of polio patients from a PHC to the lab

Answer

Transporting outdated vaccines from PHC to a district hospital

Answer

Transporting vaccine to a lab to check its potency

Answer

Transporting vaccine from a camp to a sub-centre

Question 6

The Naranjo algorithm is used for:

Accepted Answer

Calculating the probability of adverse drug reactions

Answer

Assessing environmental factors affecting drug efficacy

Answer

Parametric-based data evaluation

Answer

Evaluating demographic factors affecting drug action

Question 7

In the control of communicable diseases, the period of quarantine in respect of a disease is determined by which of the following?

Accepted Answer

Incubation period

Answer

Infectivity period

Answer

Duration of illness

Answer

Carrier state

Question 8

What does the Sullivan index measure?

Accepted Answer

Measures life expectancy adjusted for disability

Answer

Measures disability

Answer

Measures life years adjusted with disability

Answer

Measures life expectancy

Question 9

Immunity by vaccination is:

Accepted Answer

Active acquired

Answer

Active natural

Answer

Passive natural

Answer

Passive acquired

Question 10

In a case-control study, the disease is found to be more common in the group consuming coffee compared to the control group. What is the significance of this finding?

Accepted Answer

Caffeine is associated with the occurrence of the disease.

Answer

A cause and effect relationship has been established.

Answer

The median of the disease can be calculated.

Answer

Controls will not develop the disease.

Epidemiology — MCQs

Epidemiology — MCQs

On this page

Practice by Chapter

Want unlimited practice?